Results 161 to 170 of about 1,218,415 (224)

Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome.

open access: yesJ Mol Cell Cardiol, 2019
Cheng H   +6 more
europepmc   +1 more source

Personalized <i>in silico</i> modeling of cardiac ion channel variants to predict drug-induced proarrhythmia risk. [PDF]

open access: yesFront Physiol
Henedi A   +6 more
europepmc   +1 more source

Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.

open access: yesAm J Physiol Regul Integr Comp Physiol, 2019
Hull CM   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy